Neural Pharm

Neural Pharm

Share this post

Neural Pharm
Neural Pharm
How do we know it's not a placebo?

How do we know it's not a placebo?

ICER Report raises concerns about conduct of MAPP1 and MAPP2 trials. Plus Maine scraps decriminalization, and Utah opens access to MDMA and psilocybin in hospitals

Dr. Colby Burns, PharmD's avatar
Dr. Colby Burns, PharmD
Apr 04, 2024
∙ Paid
2

Share this post

Neural Pharm
Neural Pharm
How do we know it's not a placebo?
Share

Greetings and happy Hump Day readers!

This week’s post is inspired by a recent article on one of Substack’s most popular blogs (The Free Press). Author Nellie Bowles referred to a recent review article posted by the Institute for Clinical and Economic Review (ICER), an independent non-profit organization that seeks to provide a valuation on medical car…

Keep reading with a 7-day free trial

Subscribe to Neural Pharm to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Colby
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share